Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...

MPOX has the potential to become a significant global threat if international action isn’t taken now, warn scientists. Mpox ...

Mpox, once a rare virus mainly confined to parts of Central Africa, is rapidly evolving into a more serious global health ...

Uganda has received an additional 100,000 doses of the mpox vaccine from the Africa Centres for Disease Control and ...

The Company has been contracted by the U.S Biomedical Advanced Research and Development Authority (BARDA) to develop and supply a freeze-dried version of JYNNEOS for stockpiling. Manufacturing under ...

Common symptoms for Mpox include rash, fever, sore throat, headache, muscle aches, back pain, low energy, and swollen lymph nodes. Symptoms usually begin within a week but can start one to 21 days ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

Uganda has emerged as the global hotspot for Mpox, reporting the highest number of confirmed cases worldwide in the last six ...

Sex workers have been twice victimised, first by the virus and then by the stigma, but advocates hope the government will ...

A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High ...

Safer, cleaner cooking methods Uganda is transitioning to safer and cleaner cooking solutions in schools by introducing Shell ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...